Shares in Eli Lilly (NYSE:LLY) fell today even though the drugmaker beat expectations on Wall Street with its second quarter results.
The Indianapolis-based company posted profits of $1.01 billion, or 95¢ per share, on sales of $5.82 billion for the 3 months ended June 30, for bottom-line growth of 35% on sales growth of 8% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Lilly tops Q2 earnings, revenue estimates appeared first on MassDevice.
from MassDevice http://ift.tt/2vXSH00
Cap comentari:
Publica un comentari a l'entrada